NCT07118891View on ClinicalTrials.gov

Study Evaluating ABCL635 for Vasomotor Symptoms of Menopause

PHASE1RecruitingINTERVENTIONAL
Enrollment

136

Participants

Timeline

Start Date

June 23, 2025

Primary Completion Date

February 28, 2027

Study Completion Date

February 28, 2027

Conditions
Vasomotor Symptoms Associated With MenopauseHealthy Volunteers
Interventions
BIOLOGICAL

ABCL635

Participants will receive SC administrations of ABCL635

BIOLOGICAL

Placebo

Participants will receive SC administration of placebo (5% dextrose solution)

Trial Locations (2)

V5T 3N4

RECRUITING

Mount Saint Joseph Hospital Clinical Trials Phase 1 Unit, Vancouver

H3P 3P1

RECRUITING

Altasciences Company Inc., Mount Royal

Sponsors
All Listed Sponsors
lead

AbCellera Biologics Inc.

INDUSTRY